Christiane Querfeld Selected Research

Christiane Querfeld Research Topics

Disease

30	Mycosis Fungoides 09/2023 - 07/2004
28	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2023 - 09/2003
11	Neoplasms (Cancer) 01/2023 - 07/2006
10	Lymphoma (Lymphomas) 01/2022 - 12/2009
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2006
3	Dermatitis 09/2023 - 06/2018
3	Disease Progression 12/2022 - 08/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 09/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2021
2	Pruritus (Itching) 01/2019 - 12/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2018 - 09/2013
2	Fatigue 02/2014 - 08/2011
1	Anemia 10/2023
1	Large Granular Lymphocytic Leukemia 10/2023
1	Neutropenia 10/2023
1	Infections 01/2023
1	Contact Dermatitis (Eczema, Contact) 01/2022
1	Long Term Adverse Effects 01/2022
1	Exanthema (Rash) 08/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2018
1	Eczema 06/2018
1	Sarcoidosis (Schaumann Disease) 07/2016
1	Bullous Pemphigoid (Pemphigoid) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2015
1	Fibrosis (Cirrhosis) 12/2014
1	Pain (Aches) 02/2014
1	Confusion (Bewilderment) 09/2013
1	Sezary Syndrome (Sezary Erythroderma) 09/2011
1	Diarrhea 08/2011
1	Pityriasis Rubra Pilaris 08/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2009
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2007

Drug/Important Bio-Agent (IBA)

14	Mechlorethamine (Nitrogen Mustard)FDA Link 09/2023 - 09/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
3	Lenalidomide (CC 5013)FDA Link 10/2023 - 02/2014
3	TTI-621IBA 01/2023 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	CytokinesIBA 10/2023 - 01/2017
2	Rituximab (Mabthera)FDA Link 01/2021 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2014
2	pembrolizumabIBA 11/2019 - 07/2016
2	Histone Deacetylase InhibitorsIBA 01/2019 - 07/2005
2	Monoclonal AntibodiesIBA 01/2016 - 07/2005
2	enzastaurinIBA 08/2011 - 07/2006
2	Interleukin-2 (IL2)IBA 04/2007 - 07/2005
2	RetinoidsIBA 05/2006 - 07/2004
2	Bexarotene (LGD1069)FDA Link 05/2006 - 07/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Ointments (Pastes)IBA 07/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	hypericinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	dupilumabIBA 08/2021
1	mogamulizumabIBA 08/2021
1	cabazitaxel FDA Link 01/2021
1	NivolumabIBA 01/2021
1	romidepsin (FK228)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 11/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2018
1	ChemokinesIBA 01/2017
1	Brentuximab VedotinIBA 12/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	MucinsIBA 12/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2014
1	Glia Maturation Factor (GMF)IBA 09/2013
1	MethyltransferasesIBA 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	Temozolomide (Temodar)FDA LinkGeneric 09/2011
1	Sorafenib (BAY 43-9006)FDA Link 08/2011
1	Alemtuzumab (Campath)FDA Link 12/2009
1	InterleukinsIBA 04/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2006
1	Annexin A5IBA 07/2006
1	Protein Kinase C betaIBA 07/2006
1	Propidium (Propidium Iodide)IBA 07/2006
1	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2006
1	Capsules (Microcapsules)IBA 05/2006
1	CytosineIBA 07/2005
1	GuanineIBA 07/2005
1	Ficusin (Psoralen)IBA 03/2005

Therapy/Procedure

28	Therapeutics 10/2023 - 09/2003
6	Immunotherapy 01/2023 - 01/2017
2	Duration of Therapy 09/2023 - 01/2021
2	Radiotherapy 09/2013 - 03/2013
1	Aftercare (After-Treatment) 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Injections 11/2021
1	Hematopoietic Stem Cell Transplantation 07/2015
1	Transplantation 07/2015
1	Drug Therapy (Chemotherapy) 09/2013
1	Photopheresis 10/2012
1	Subcutaneous Injections 04/2007